IROZINC

This brand name is authorized in Turkey

Active ingredients

The drug IROZINC contains a combination of these active pharmaceutical ingredients (APIs):

1 Ferrous fumarate
UNII R5L488RY0Q - FERROUS FUMARATE

Ferrous fumarate is an easily absorbed source of iron for replacement therapy. It is a salt of ferrous iron with an organic acid and is less irritant to the gastro-intestinal tract than salts with inorganic acids. Iron and iron salts should be given for the treatment or prophylaxis of iron deficiency anaemias.

Read about Ferrous fumarate
2 Zinc sulfate
UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM

Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children.

Read about Zinc sulfate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B03AE10 Various combinations B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AE Iron in other combinations
Discover more medicines within B03AE10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8680150150019

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.